KAIST researchers develop drug that regenerates retinal nerves to restore vision
KAIST researchers have developed a novel drug that can restore vision by regenerating retinal nerves, addressing a critical gap where existing treatments only slow disease progression but cannot reverse vision loss. This breakthrough offers hope to over 300 million people worldwide at risk of vision loss from retinal diseases.
Key quotes
KAIST researchers have successfully developed a novel drug to restore vision.
Vision is one of the most crucial human senses, yet over 300 million people worldwide are at risk of vision loss due to various retinal diseases.
No effective therapy has been developed to restore already lost vision-until now.
From the article
You might also wanna read
Jackson Laboratory and Broad Institute receive $34.5M ARPA-H award for pediatric epilepsy gene editing platform
The Jackson Laboratory (JAX), in partnership with the Broad Institute and other collaborators, has been selected for an up to $34.5 million
Public perspectives on collecting and sharing pharmacogenomic test results for major depressive disorder
This article explores public perspectives on collecting and sharing pharmacogenomic (PGx) test results for major depressive disorder (MDD).
1946 US Navy asbestos study that downplayed health risks faces retraction call
An 80-year-old 1946 US Navy study that concluded covering pipes with asbestos was not dangerous is facing a call for retraction. The study,
Colorado Researchers Develop Regenerative Shot That Reverses Osteoarthritis in Animal Models
Researchers in Colorado are developing two new therapies for osteoarthritis, including a single regenerative shot that could restore affecte
Bacteria Can Store and Pass Down Memories, Study Finds, With Implications for Antibiotic Resistance
This article explores the emerging field of research showing that bacteria and other single-celled organisms can store information, learn fr
Molecular Jackhammer Technique Using Light and Dyes Destroys 99% of Cancer Cells in Lab Tests
Scientists have developed a novel cancer treatment technique called 'molecular jackhammer' that uses aminocyanine molecules (synthetic dyes

Comments
Sign in to join the conversation.
No comments yet. Be the first.